ID Analysts

Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.

Analyst Articles

This morning we closed out our Petrokazakhstan call option trade for a one-day gain of 47 percent. This is a classic case of being right for the wrong reason. The Canadian company with the decidedly non-Canadian name had been depressed in recent weeks on fears that it would face a… Read More

Image by Getty Images via Daylife Weekly Update  Stocks appear poised to end the year on a high note. Fourth-quarter retail sales will likely top expectations and other measures indicate the economy remains healthy. With oil prices more than $10 below where they were… Read More

Today’s action notwithstanding, Schlumberger (SLB, $66.33) has gotten a boost from crude oil, which has risen in the past week. Regardless of the near-term fluctuations in energy prices, the big oil companies are increasing their exploration budgets. And with its dominant position in the oil service industry, Schlumberger will be… Read More

Image by Homer Township Public Library via Flickr Weekly Update  Stocks continue to advance today, following yesterday’s strong gains. Today’s rally is being fueled by a sizeable build-up in oil inventories, which is putting pressure on energy prices, and revised third-quarter GDP figures, which show… Read More

Schlumberger (SLB, $65.63) has been the laggard among the oil service stocks this year, but given its dominant position in its industry the company is a sure beneficiary of the increase in capital spending we’re starting to see by the major oil firms. That’s why we added the May 65… Read More

Image via Wikipedia Weekly Update  The biggest non-story of the week has been the Federal Reserve’s latest confab. Greenspan & Co. followed through on their promise and raised short-term interest rates yesterday for the fifth time this year. That brings the Fed Funds rate to… Read More

We’ve been relatively busy in the past week. We closed out the December 25 Teva call option for a loss of 7 percent. The Teva loss was a tough one to take since we were right on the stock’s direction but got beat on the trade nonetheless due to erosion… Read More

Image via Wikipedia Weekly Update  If there’s one constant in investing it’s that markets never move in a straight line. But despite the recent action in share prices and the growing chorus of voices expecting a shakeout in equities, the near-term trend for stocks remains… Read More

This morning we closed out a 1-day position in the Allergan January 75 call option for a profit of 43 percent, based on our entry point of $2.85. The stock rebounded as we expected after it became clear Allergan’s BOTOX was not the cause of a Florida couple being hospitalized… Read More

Image by Getty Images via Daylife Weekly Update  Can you hear me now? On this date in 1878 the White House installed its first telephone, allowing for the rapid transmission of vocal messages to and from the seat of our government. Today, stocks are… Read More